TNF and herpes zoster: However, a subanalysis of the patients treated with TNF-α inhibitors showed a relatively lower incidence of herpes zoster (16.06 vs. 17.86 per 1000 PY) and MACEs (3.95 vs. 7.02 per 1000 PY) in patients with PsA compared with those without PsA.